跳至主要内容
临床试验/NCT01540578
NCT01540578已完成不适用

OBSERVATIONAL: Replication Profiling as a Diagnostic Tool in B-cell Acute Lymphoblastic Leukemia (ALL)

Children's Oncology Group1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2012年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
70
试验地点
1
主要终点
Replication-timing changes as a biomarker for further risk prediction by FISH

研究概览

简要总结

This clinical trial is studying biomarkers as a diagnostic tool in samples from younger patients with B-cell acute lymphoblastic leukemia. Finding specific biomarkers may help improve the treatment of patients with B-cell acute lymphoblastic leukemia

详细描述

STUDY SUBTYPE: Ancillary/Correlative

OBSERVATIONAL STUDY MODEL: Case-only

TIME PERSPECTIVE: Retrospective

BIOSPECIMEN RETENTION: Samples with DNA

BIOSPECIMEN DESCRIPTION: Fresh and frozen bone marrow cells

研究设计

研究类型
Observational
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Frozen viable cell samples from patients with B-cell acute lymphoblastic (ALL) of any outcome from the Children's Oncology Group (COG) ALL Cell Bank (Part 1)
  • Freshand frozen cell samples from patients with B-cell ALL with known outcomes from the COG ALL Cell Bank (Part 2) meeting 1 of the following criteria:
  • Samples from patients who experienced an early recurrence within 36 months of diagnosis (cases)
  • Samples from patients who remain in prolonged remission (controls)
  • No samples meeting either of the following criteria:
  • Very-high-risk features
  • Philadelphia chromosome positive
  • Hypodiploid
  • MLL (11q23) rearranged
  • Known favorable risk factors
  • Hyperdiploid
  • t(12;21) (ETV6/RUNX1)

排除标准

  • 未提供

结局指标

主要结局

Replication-timing changes as a biomarker for further risk prediction by FISH

时间窗: 2 months

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验